NON-HODGKIN'S LYMPHOMA

Clinical trials for NON-HODGKIN'S LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new NON-HODGKIN'S LYMPHOMA trials appear

Sign up with your email to follow new studies for NON-HODGKIN'S LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 2 Completed 1

Could a drug make stem cell transplants safer and more effective?

Disease control Completed

This study tested a drug called palifermin in 34 adults with blood cancers who received stem cell transplants from unrelated donors. The goal was to see if palifermin could reduce severe chronic graft-versus-host disease (GVHD), a serious complication where donor cells attack the…

Matched conditions: NON-HODGKIN'S LYMPHOMA

Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated May 08, 2026 12:04 UTC

NON-HODGKIN'S LYMPHOMA

Get alerted when new NON-HODGKIN'S LYMPHOMA trials appear

Could a drug make stem cell transplants safer and more effective?